|
|
||||||||
Eur J Cardiothorac Surg 2004;26:S57-S58
© 2004 Elsevier Science NL
Review |
a Department of Cardio-Thoracic Surgery, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
b Department of Cardiac Surgery, University Hospital Innsbruck, Innsbruck, Austria
* Corresponding author. Tel.: +43 1 40400 5644; fax: +43 1 40400 5642. (Email: walter.klepetko{at}meduniwien.ac.at).
Lung and heart tranplantations are accepted standard therapies for end stage diseases and will maintain their importancy in the future. Potentially, transplantation at a cellular level using various forms of stem cells becomes an additional therapeutic approach.
Key Words: Thoracic transplantation Allotransplant Donor pool Xenotransplantation Stem cell therapy
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |